CIGB 2020 vaccine

3 trials

Sponsors

Center for Genetic Engineering and Biotechnology (CIGB), in Havana, Center for Genetic Engineering and Biotechnology (CIGB)

Conditions

Acute Respiratory Infection (ARI) COVID-19 SARS-CoV2Contacts and SARS-CoV-2 infection suspects suspected of SARS-CoV-2 infectionimmunosenescence

Phase 2

CIGB 2020 in contacts and SARS-CoV-2 infection suspects

RecruitingRPCEC00000306

Center for Genetic Engineering and Biotechnology (CIGB), in HavanaContacts and SARS-CoV-2 infection suspects suspected of SARS-CoV-2 infection

Start: 2020-03-27Target: 80Updated: 2026-03-30

Safety and immunogenicity of the CIGB 2020.

Active, not recruitingRPCEC00000326

Center for Genetic Engineering and Biotechnology (CIGB), in Havanaimmunosenescence

Start: 2020-07-29Target: 40Updated: 2026-03-30

Unknown Phase

CIGB2020- ARI elderly contacts

Active, not recruitingRPCEC00000356

Center for Genetic Engineering and Biotechnology (CIGB)Acute Respiratory Infection (ARI) COVID-19 SARS-CoV2

Start: 2021-03-12Target: 1440Updated: 2026-03-30

Related Papers

HeberNasvac, a Nasal and Sublingual Vaccine Formulation with Interferons Inducing Capacity

The American Journal of Public Health2025-12-30